The global prostate-specific antigen (psa) test market size was valued at USD 3,276.9 million in 2022 and is poised to grow at a significant CAGR of 11.5% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029.